Abbott Laboratories stock outperforms competitors despite losses on the day
This was the stock's third consecutive day of losses.
Hosted on MSN20h
Is Abbott Laboratories Stock Underperforming the Nasdaq?
Valued at a market cap of $202.6 billion, North Chicago, Illinois-based Abbott Laboratories (ABT) is a global healthcare ...
Piper Sandler Sticks to Its Buy Rating for Abbott Laboratories (ABT)
Piper Sandler analyst Adam Maeder maintained a Buy rating on Abbott Laboratories (ABT – Research Report) today and set a price target of ...
Medical Design and Outsourcing16h
Abbott’s device group had a supply chain ‘mind shift,’ Lisa Earnhardt says
Abbott medical device leader Lisa Earnhardt says her group wants fewer suppliers — but to make them into long-term partners.
Abbott Laboratories (NYSE:ABT) Short Interest Down 14.4% in November
Abbott Laboratories (NYSE:ABT – Get Free Report) saw a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 12,050,000 shares, a ...
bovnews1d
Abbott Laboratories (ABT) Stock: Greater Than Its Current Valuation?
On Friday, Abbott Laboratories (ABT) stock saw a decline, ending the day at $118.93 which represents a decrease of $-0.02 or -0.02% from the prior close of $118.95. The stock opened at $118.71 and ...
MarketWatch7d
Abbott Laboratories stock underperforms Tuesday when compared to competitors
Shares of Abbott Laboratories ABT slipped 0.14% to $117.96 Tuesday, on what proved to be an all-around great trading session ...
Abbott Laboratories: Investors Should Wait For A Pullback
Abbott Laboratories' revenue and return on invested capital could be more consistent. Read why potential investors will need ...